Bank Of Montreal Pax Medica, Inc. Transaction History

Bank Of Montreal

  • $197 Billion
  • Q2 2024

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Nov 10, 2022
BUY
$2.25 - $43.69 $33,750 - $655,350
15,000 New
15,000 $59,000

About PaxMedica, Inc.

PXMD Quotes by TradingView
  • Ticker PXMD
  • Exchange
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 11,779,500
  • Market Cap $1.06M
  • Description
  • PaxMedica, Inc., a clinical stage biopharmaceutical company, focuses on the development of anti-purinergic drug therapies (APT) for the treatment of disorders with intractable neurologic symptoms. The company's lead product candidate is PAX-101, an intravenous formulation of suramin for various indications, including autism spectrum disorder, my...
More about PXMD
Track This Portfolio

Track Bank Of Montreal Portfolio

Follow Bank Of Montreal and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bank Of Montreal , based on Form 13F filings with the SEC.

News

Stay updated on Bank Of Montreal with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email